Application Number: AU 2026201970

Systems and Methods for Health Data Visualization and User Support Tools for Continuous Glucose Monitoring Turning a Stream of Glucose Readings Into a Clear Picture

The patent provides systems and methods for generating graphical displays of [analyte](https://en.wikipedia.org/wiki/Analyte) data, such as glucose readings, and related health information. The displays are built from what the filing calls a self-referential dataset, meaning the visualisation can be modified based on identified portions of the data itself, so the resulting graphics highlight notable features in

Open for Public Inspection
AU 2026201970 Featured Image

View the Systems and Methods for Health Data Visualization and User Support Tools for Continuous Glucose Monitoring PDF

Download the PDF version of this Application Open to Public Inspection

This patent describes ways to turn the constant stream of data from a continuous glucose monitor into clear graphical displays that help a person with diabetes understand and act on their glucose levels. It comes from Dexcom, Inc., a leading maker of continuous glucose monitoring systems.

The Problem

People managing diabetes used to check their glucose only a few times a day with a finger-prick test, which left long gaps and gave no sense of whether levels were rising or falling. Continuous glucose monitors changed that by measuring glucose every few minutes through a small skin sensor, but they create a different challenge: a flood of data points that is hard to make sense of in the moment. A list of numbers does not easily reveal patterns, trends, or the times of day when problems recur. To be useful, that continuous data has to be presented in a way that highlights what matters, supports decisions, and does not overwhelm the user. The difficulty is generating displays that adapt to the data and surface the meaningful features rather than just plotting raw values.

What This Invention Does

The patent provides systems and methods for generating graphical displays of analyte data, such as glucose readings, and related health information. The displays are built from what the filing calls a self-referential dataset, meaning the visualisation can be modified based on identified portions of the data itself, so the resulting graphics highlight notable features in a person’s glucose history. By generating dynamic data structures and adapting the display to the readings, the approach turns a continuous stream into views that emphasise trends, patterns, and events a user or clinician needs to notice. Alongside the displays, the filing covers user support tools that help a person interpret and respond to their glucose information. The result is a clearer, more actionable picture of glucose over time rather than an undifferentiated graph.

Key Features

  • Adaptive displays. Graphical views are generated from the data and modified based on identified portions of it.
  • Feature highlighting. The displays surface notable features in a person’s glucose history rather than raw values alone.
  • Dynamic data structures. The system builds data structures that drive the visualisations as new readings arrive.
  • User support tools. Accompanying tools help the user interpret and act on their glucose information.
  • Built for continuous data. The approach is designed for the steady stream from a continuous glucose sensor.

Who Is Behind It

The applicant is Dexcom, Inc., a company based in San Diego, California, that designs and manufactures continuous glucose monitoring systems used worldwide by people with diabetes. The filing names a large group of inventors from the company’s product and engineering teams, reflecting the breadth of work on its display and software tools. This filing is a divisional application from an earlier related Australian application.

Why It Matters

Continuous glucose monitoring only helps if people can actually understand and act on what it shows, so the way the data is visualised is as important as the sensor itself. Displays that adapt to the data and highlight what matters can make day-to-day diabetes management easier and safer. Protecting the systems and methods in Australia supports the company’s products and commercial activity in the local market.

Related Concepts


AU 2026201970 was published in the Australian Official Journal of Patents on 2 April 2026 and is open for public inspection. Patent applications represent inventions that are sought to be protected and do not necessarily reflect commercially available products.

Related Patents Open to Public Inspections

See related Patents open to public inspection.

Open for Public Inspection

Smarter Biosensors

Application Number: AU 2026201605 Filed:03/03/26 | Published: 19/03/26
Disclaimer

The information presented in this article is provided for general informational and illustrative purposes only.

Content on this page may be derived from publicly available intellectual property records, including patent documentation and related materials. While reasonable care is taken in compiling and summarising this information, ATMOSS does not guarantee the accuracy, completeness, currency, or reliability of any content presented.

This article is not a substitute for reviewing the original source documents. Patent applications, specifications, claims, and related records may contain detailed technical, legal, and contextual information that is not fully represented in this summary.


ATMOSS does not provide legal, technical, or commercial advice. Users should not rely on this content for decision-making purposes.
For authoritative and up-to-date information, users should refer directly to the official records available via IP Australia and other relevant intellectual property databases. Links to these official sources are provided where applicable.


ATMOSS accepts no liability for any loss, damage, or consequences arising from the use of, or reliance on, the information contained in this article.